Related Experiment Video
Updated: Nov 5, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Cellular Immune Response to COVID-19 and Potential Immune Modulators
1National Clinical Research Center for Child Health, National Children's Regional Medical Center, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Understanding COVID-19 severity involves analyzing immune responses. Severe cases show distinct immune stages, guiding potential treatments like type I interferon (IFN) and immunoglobulin therapies.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents heterogeneous clinical outcomes.
- Transmission occurs mainly through droplets and contact.
- Factors influencing COVID-19 outcomes, particularly host-related immune responses, require further characterization.
Purpose of the Study:
- To elucidate the relationship between host immune responses and COVID-19 severity.
- To identify distinct stages of immune response in fatal COVID-19 cases.
- To propose stage-specific therapeutic interventions for severe COVID-19.
Main Methods:
- Analysis of immune response kinetics in patients with varying COVID-19 severity.
- Characterization of immune profiles in mild, severe, and fatal COVID-19 cases.
- Literature review on immune responses in infectious diseases.
Main Results:
- COVID-19 severity is primarily linked to host cellular immune responses.
- Fatal severe COVID-19 involves a three-stage immune response: hypofunction, hyperactivation, and anergy.
- Mild and recovering severe cases exhibit effective viral clearance via normal immune responses.
Conclusions:
- Type I interferon (IFN) may benefit patients in the hypofunctional stage of severe COVID-19.
- Intravenous immunoglobulin (IVIG) and glucocorticoid therapy are suggested for the hyperactivation stage.
- Anticoagulation with low molecular weight heparin (LMWH) and antibiotic therapy are recommended during the hyperactivation stage.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Humoral Immune Responses
Cells of the Adaptive Immune Response
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

